Search research articles
Contact Us
Filters
Showing results (101-110 of 180) with videos related to
Page
of 18
Sort By:
European Radiology
|
December 11, 2013
Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT
Katrijn Michielsen, Ignace Vergote, Katya Op de Beeck, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
February 15, 2018
Acute Drug Effects on the Human Placental Tissue: The Development of a Placental Murine Xenograft Model
Magali Verheecke, Els Hermans, Sandra Tuyaerts, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 19, 2025
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy
Robert Fruscio, Rita Trozzi, Stefania Galimberti, et al.
BMJ Open
|
March 28, 2024
Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study
Ilana Struys, Carolina Velázquez, Koenraad Devriendt, et al.
Human Pathology
|
January 25, 2014
Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues
Oscar Maiques, Maria Santacana, Joan Valls, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2011
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
Jone Trovik, Elisabeth Wik, Ingunn M Stefansson, et al.
Histopathology
|
October 30, 2014
FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA
Oscar Maiques, Dolors Cuevas, Diego Andrés García Dios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer
Ignace B Vergote, Radoslav Chekerov, Frederic Amant, et al.
Journal of Gynecologic Oncology
|
July 23, 2019
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
Peey Sei Kok, Philip Beale, Rachel L O'Connell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2019
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4
Pien Lof, Roelien van de Vrie, Catharina M Korse, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 180) with videos related to
Sort By:
Page
of 18
European Radiology
|
December 11, 2013
Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT
Katrijn Michielsen, Ignace Vergote, Katya Op de Beeck, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
February 15, 2018
Acute Drug Effects on the Human Placental Tissue: The Development of a Placental Murine Xenograft Model
Magali Verheecke, Els Hermans, Sandra Tuyaerts, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 19, 2025
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy
Robert Fruscio, Rita Trozzi, Stefania Galimberti, et al.
BMJ Open
|
March 28, 2024
Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study
Ilana Struys, Carolina Velázquez, Koenraad Devriendt, et al.
Human Pathology
|
January 25, 2014
Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues
Oscar Maiques, Maria Santacana, Joan Valls, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2011
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
Jone Trovik, Elisabeth Wik, Ingunn M Stefansson, et al.
Histopathology
|
October 30, 2014
FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA
Oscar Maiques, Dolors Cuevas, Diego Andrés García Dios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer
Ignace B Vergote, Radoslav Chekerov, Frederic Amant, et al.
Journal of Gynecologic Oncology
|
July 23, 2019
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
Peey Sei Kok, Philip Beale, Rachel L O'Connell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2019
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4
Pien Lof, Roelien van de Vrie, Catharina M Korse, et al.
Page
of 18